MTNR1B and type 2 diabetes mellitus: This could be particularly problematic in MTNR1B subjects, carriers of the common MTNR1B T2D risk variant G, not only because melatonin signaling is higher due to an increased receptor expression, but also because in these subjects, the duration of elevated melatonin levels may be extended with a delayed decline in the morning [73].